胸腔镜与传统手术治疗非小细胞肺癌的临床疗效分析

Clinical analysis of video-assisted thoracic surgery versus traditional thoracotomy for non-small cell lung cancer

目的探讨电视胸腔镜(VATS)肺叶切除术治疗非小细胞肺癌(NSCLC)的临床疗效。方法将150例非小细胞肺癌患者随机分为观察组(75例)和对照组(75例),观察组患者采用VATS治疗,对照组患者采用传统开胸手术治疗,观察两组患者的临床疗效。结果观察组患者手术时间、术中出血量、切口长度、住院时间及并发症的发生率明显少于对照组,组间差异有统计学意义(P<0.05);但观察组患者淋巴结清扫数目与对照组比较,差异无统计学意义(P>0.05)。观察组患者复发率明显低于对照组,3年生存率明显高于对照组,组间差异有统计学意义(P<0.05)。结论电视胸腔镜肺叶切除术治疗NSCLC安全有效,值得临床推广使用。

Objective To study the clinical efficacy of video-assisted thoracoscopic lobectomy in non-small cell lung cancer. Methods 150 patients with non-small cell lung cancer（NSCLC） were random- ly divided into observation group （75 cases）and control group（75 cases） ,observation group was treated by video-assisted thoracopic surgery （ VATS）, the control group was treated by conventional thoracotomy, ob- served the clinical efficacy after the operation. Results The operative time, the blood loss, the length of operative incision, the length of hospital stay and the incidence of complications of the VATS group were less than the conventional thoracotomy group（P 〈 0. 05）, but the number of lymph nodes of the two groups had no statistically significant（ P 〉 0. 05 ）. The recurrence rate of the VATS group was lower than the the conventional thoracotomy group, the 3-year survival rate was higher （ P 〈 O. 05 ）. Conclusions Video-as- sisted thoracoscopic lobectomy is safe and feasible in the treatment in non-small cell lung cancer,it was wor- thy to be popularized.